关注
Tone Frost Bathen
Tone Frost Bathen
Professor
在 ntnu.no 的电子邮件经过验证
标题
引用次数
引用次数
年份
Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters
B Sitter, S Lundgren, TF Bathen, J Halgunset, HE Fjosne, IS Gribbestad
NMR in Biomedicine: An International Journal Devoted to the Development and …, 2006
2772006
Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness
GF Giskeødegård, H Bertilsson, KM Selnæs, AJ Wright, TF Bathen, T Viset, ...
PloS one 8 (4), e62375, 2013
2052013
Breast cancer quantitative proteome and proteogenomic landscape
HJ Johansson, F Socciarelli, NM Vacanti, MH Haugen, Y Zhu, I Siavelis, ...
Nature communications 10 (1), 1600, 2019
1802019
Dynamic contrast‐enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced …
JR Teruel, MG Heldahl, PE Goa, M Pickles, S Lundgren, TF Bathen, ...
NMR in Biomedicine 27 (8), 887-896, 2014
1642014
MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status
TF Bathen, LR Jensen, B Sitter, HE Fjösne, J Halgunset, DE Axelson, ...
Breast cancer research and treatment 104, 181-189, 2007
1622007
Metabolic characterization of triple negative breast cancer
MD Cao, S Lamichhane, S Lundgren, A Bofin, H Fjøsne, ...
BMC cancer 14, 1-12, 2014
1592014
Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy
B Sitter, TF Bathen, TE Singstad, HE Fjøsne, S Lundgren, J Halgunset, ...
NMR in Biomedicine: An International Journal Devoted to the Development and …, 2010
1582010
Multivariate modeling and prediction of breast cancer prognostic factors using MR metabolomics
GF Giskeødegård, MT Grinde, B Sitter, DE Axelson, S Lundgren, ...
Journal of proteome research 9 (2), 972-979, 2010
1552010
Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE‐MRI
R Johansen, LR Jensen, J Rydland, PE Goa, KA Kvistad, TF Bathen, ...
Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2009
1512009
T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results
G Nketiah, M Elschot, E Kim, JR Teruel, TW Scheenen, TF Bathen, ...
European radiology 27, 3050-3059, 2017
1502017
Merging transcriptomics and metabolomics-advances in breast cancer profiling
E Borgan, B Sitter, OC Lingjærde, H Johnsen, S Lundgren, TF Bathen, ...
BMC cancer 10, 1-14, 2010
1312010
HR MAS MR spectroscopy in metabolic characterization of cancer
S Moestue, B Sitter, T Frost Bathen, MB Tessem, I Susann Gribbestad
Current topics in medicinal chemistry 11 (1), 2-26, 2011
1212011
Magnetic resonance metabolomics of intact tissue: a biotechnological tool in cancer diagnostics and treatment evaluation
TF Bathen, B Sitter, TE Sjøbakk, MB Tessem, IS Gribbestad
Cancer Research 70 (17), 6692-6696, 2010
1162010
High-resolution magic angle spinning (HR MAS) MR spectroscopy in metabolic characterization of human cancer
B Sitter, TF Bathen, MB Tessem, IS Gribbestad
Progress in nuclear magnetic resonance spectroscopy 54 (3-4), 239-254, 2009
1112009
Cervical cancer tissue characterized by high-resolution magic angle spinning MR spectroscopy
B Sitter, T Bathen, B Hagen, C Arentz, FE Skjeldestad, IS Gribbestad
Magnetic Resonance Materials in Physics, Biology and Medicine 16, 174-181, 2004
1072004
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome
MR Aure, V Vitelli, S Jernström, S Kumar, M Krohn, EU Due, TH Haukaas, ...
Breast Cancer Research 19, 1-18, 2017
1022017
Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia
GF Giskeødegård, AF Hansen, H Bertilsson, SV Gonzalez, KA Kristiansen, ...
British journal of cancer 113 (12), 1712-1719, 2015
1022015
Predicting long‐term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling
MD Cao, B Sitter, TF Bathen, A Bofin, PE Lønning, S Lundgren, ...
NMR in Biomedicine 25 (2), 369-378, 2012
1012012
IDH1 R132H mutation generates a distinct phospholipid metabolite profile in glioma
M Esmaeili, BC Hamans, AC Navis, R van Horssen, TF Bathen, ...
Cancer research 74 (17), 4898-4907, 2014
1002014
Diffusion‐weighted and dynamic contrast‐enhanced MRI in evaluation of early treatment effects during neoadjuvant chemotherapy in breast cancer patients
LR Jensen, B Garzon, MG Heldahl, TF Bathen, S Lundgren, IS Gribbestad
Journal of Magnetic Resonance Imaging 34 (5), 1099-1109, 2011
972011
系统目前无法执行此操作,请稍后再试。
文章 1–20